POWERFUL COLLABORATION
Learn more about the MMRC’s efforts to bring new treatments to patients – faster. EXPANDED ACCESS PROGRAMThe MMRF teams up with Onyx Pharmaceuticals to bring carfilzomib to patients with advanced multiple myeloma through C-MAP. Click here to see if you are eligible* for this new treatment option. IN THE SPOTLIGHTWe Bring the Myeloma Experts to You!Couldn’t make the last MMRF Clinical Insights? Learning about new treatment options from the world’s leading myeloma doctors is just a few clicks away. Watch today! |
LANDMARK RESEARCHThe MMRF is excited to announce its newest initiative, the MMRF CoMMpass℠ (Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile) Study. This long term study will use principles of personalized medicine to generate hypotheses that may lead to new treatments for multiple myeloma, ultimately charting a course to a cure. NEWSMay 4, 2012: 10th Anniversary Multiple Myeloma Research Foundation (MMRF) Laugh for Life: New York Raises Critical Funds for Blood Cancer ResearchApril 13, 2012: Local and National Stars Honored at the Multiple Myeloma Research Foundation (MMRF) 12th Annual Chicago Awards Dinner to Raise Urgent Funds for Cancer ResearchApril 10, 2012: Multiple Myeloma Research Consortium (MMRC) and Synta Pharmaceuticals Announce First Patient in Clinical Trial in Multiple MyelomaApril 9, 2012: The Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) Appoint Michael N. Needle, M.D., Chief Medical Officer |
EVENTSJoin an MMRF event or start your own event. Together we can make a real difference for myeloma patients. MMRF Endurance Events
Shop the MMRF Store
|



Experience the thrill of being on the MMRF PowerTeam at one of our upcoming Fall marathons. Spots filling fast for 

